A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.

Vitamin D receptor (VDR)-mediated 1,25-dihydroxyvitamin D3 (1,25(OH)2D3)-dependent gene expression is compromised in the VDR null mouse. The biological consequences include: hypocalcemia, hypophosphatemia, elevated parathyroid hormone (PTH) and 1,25(OH)2D3, and consequential skeletal abnormalities. CYP24A1 is a cytochrome P450 enzyme that is involved in the side chain oxidation and destruction of both 1,25(OH)2D3 and 25-hydroxyvitamin D3 (25-OH-D3). In the current studies, we used liquid chromatography-tandem mass spectrometry technology to compare the metabolic profiles of VDR null mice fed either a normal or a calcium and phosphate-enriched rescue diet and to assess the consequence of transgenic expression of either mouse or human VDR genes in the same background. Serum 1,25(OH)2D3 levels in VDR null mice on normal chow were highly elevated (>3000 pg/mL) coincident with undetectable levels of catabolites such as 24,25-(OH)2D3 and 25-OH-D3-26,23-lactone normally observed in wild-type mice. The rescue diet corrected serum Ca(++), PTH, and 1,25(OH)2D3 values and restored basal expression of Cyp24a1 as evidenced by both renal expression of Cyp24a1 and detection of 24,25-(OH)2D3 and the 25-OH-D3-26,23-lactone. Unexpectedly, this diet also resulted in supranormal levels of 3-epi-24,25-(OH)2D3 and 3-epi-25-OH-D3-26,23-lactone. The reappearance of serum 24,25-(OH)2D3 and renal Cyp24a1 expression after rescue suggests that basal levels of Cyp24a1 may be repressed by high PTH. Introduction of transgenes for either mouse or human VDR also normalized vitamin D metabolism in VDR null mice, whereas this metabolic pattern was unaffected by a transgene encoding a ligand binding-deficient mutant (L233S) human VDR. We conclude that liquid chromatography-tandem mass spectrometry-based metabolic profiling is an ideal analytical method to study mouse models with alterations in calcium/phosphate homeostasis.

[1]  J. Pike,et al.  The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D3 , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components* , 2015, The Journal of Biological Chemistry.

[3]  J. Goellner,et al.  A DNA Segment Spanning the Mouse Tnfsf11 Transcription Unit and Its Upstream Regulatory Domain Rescues the Pleiotropic Biologic Phenotype of the RANKL Null Mouse , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  D. Moras,et al.  A vitamin D receptor selectively activated by gemini analogs reveals ligand dependent and independent effects. , 2015, Cell reports.

[5]  J. Goellner,et al.  A humanized mouse model of hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. , 2014, Endocrinology.

[6]  J. Goellner,et al.  Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype. , 2014, Endocrinology.

[7]  H. DeLuca,et al.  Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. , 2014, The Journal of clinical endocrinology and metabolism.

[8]  W. Kuebler,et al.  Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. , 2014, Molecular endocrinology.

[9]  H. DeLuca,et al.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo , 2013, Proceedings of the National Academy of Sciences.

[10]  J. Fleet,et al.  Villin promoter‐mediated transgenic expression of transient receptor potential cation channel, subfamily V, member 6 (TRPV6) increases intestinal calcium absorption in wild‐type and vitamin D receptor knockout mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Glenville Jones,et al.  25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. , 2012, Archives of biochemistry and biophysics.

[12]  R. St-Arnaud,et al.  Vitamin D metabolism, cartilage and bone fracture repair , 2011, Molecular and Cellular Endocrinology.

[13]  J. Pike,et al.  Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand , 2011, Molecular and Cellular Endocrinology.

[14]  Glenville Jones,et al.  Bioengineering Anabolic Vitamin D-25-Hydroxylase Activity into the Human Vitamin D Catabolic Enzyme, Cytochrome P450 CYP24A1, by a V391L Mutation* , 2011, The Journal of Biological Chemistry.

[15]  M. Haussler,et al.  Vitamin D Receptor: Key Roles in Bone Mineral Pathophysiology, Molecular Mechanism of Action, and Novel Nutritional Ligands , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  C. Kovacs,et al.  The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice. , 2005, American journal of physiology. Endocrinology and metabolism.

[17]  C. Carlberg,et al.  A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling. , 2004, Chemistry & biology.

[18]  S. Kato,et al.  Metastatic growth of lung cancer cells is extremely reduced in Vitamin D receptor knockout mice , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[19]  D. Miao,et al.  Inactivation of the 25-Hydroxyvitamin D 1α-Hydroxylase and Vitamin D Receptor Demonstrates Independent and Interdependent Effects of Calcium and Vitamin D on Skeletal and Mineral Homeostasis* , 2004, Journal of Biological Chemistry.

[20]  Wei Zheng,et al.  Altered gene expression profile in the kidney of vitamin D receptor knockout mice , 2003, Journal of cellular biochemistry.

[21]  S. Kato,et al.  Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. , 2003, The Journal of nutrition.

[22]  R. Balling,et al.  Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. , 2002, Molecular endocrinology.

[23]  H. DeLuca,et al.  Parathyroid hormone regulates 25-hydroxyvitamin D3-24-hydroxylase mRNA by altering its stability , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Carmeliet,et al.  Duodenal calcium absorption in vitamin D receptor–knockout mice: Functional and molecular aspects , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Inouye,et al.  Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. , 2000, European journal of biochemistry.

[26]  S. Kato,et al.  Positive and Negative Regulations of the Renal 25-Hydroxyvitamin D3 1α-Hydroxylase Gene by Parathyroid Hormone, Calcitonin, and 1α,25(OH)2D3 in Intact Animals. , 1999, Endocrinology.

[27]  H. DeLuca,et al.  Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.

[28]  R. Baron,et al.  Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. , 1998, Endocrinology.

[29]  R. Baron,et al.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Tatsuya Yoshizawa,et al.  Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.

[31]  西村篤.  Regulation of Messenger Ribonucleic Acid Expression of 1α,25-Dihydroxyvitamin D3-24-Hydroxylase in Rat Osteoblasts(骨芽細胞における1α,25-ジヒドロキシビタミンD3-24-水酸化酵素mRNAの発現調節) , 1996 .

[32]  M. Noshiro,et al.  Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts. , 1994, Endocrinology.

[33]  M. Noshiro,et al.  Parathyroid hormone inhibits 25-hydroxyvitamin D3-24-hydroxylase mRNA expression stimulated by 1 alpha,25-dihydroxyvitamin D3 in rat kidney but not in intestine. , 1992, The Journal of biological chemistry.

[34]  M. Noshiro,et al.  Cloning and expression of cDNA encoding 25‐hydroxyvitamin D3 24‐hydroxylase , 1991, FEBS letters.

[35]  R. Horst,et al.  Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. , 1990, Endocrinology.

[36]  Glenville Jones,et al.  1,25‐dihydroxyvitamin D3 metabolism in a human osteosarcoma cell line and human bone cells , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  H. DeLuca,et al.  Rat renal 25-hydroxyvitamin D3 1- and 24-hydroxylases: their in vivo regulation. , 1984, The American journal of physiology.

[38]  H. DeLuca,et al.  25-Hydroxyvitamin D3 26,23-lactone: a new in vivo metabolite of vitamin D. , 1979, Biochemistry.

[39]  R. Horst,et al.  25-OHD3-26,23-lactone: a metabolite of vitamin D3 that is 5 times more potent than 25-OHD3 in the rat plasma competitive protein binding radioassay. , 1979, Biochemical and biophysical research communications.